Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shitij Kapur

Showing results (1-10 of 243) with videos related to

Pageof 25
Sort By:
Schizophrenia Research|May 3, 2011
What Kraepelin might say about schizophrenia: just the factsShitij Kapur
Trends in Pharmacological Sciences|July 28, 2004
How antipsychotics become anti-"psychotic"--from dopamine to salience to psychosisShitij Kapur
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|March 8, 2011
Looking for a "biological test" to diagnose"schizophrenia": are we chasing red herrings?Shitij Kapur
The American Journal of Psychiatry|December 31, 2002
Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophreniaShitij Kapur
Schizophrenia Bulletin|July 24, 2010
Antipsychotic dosing: how much but also how often?Gary Remington, Shitij Kapur
Evidence-Based Mental Health|August 16, 2002
Review: amisulpride is effective and safe for schizophreniaGary Remington, Shitij Kapur
JAMA Psychiatry|March 28, 2019
Small Sample Sizes and a False Economy for Psychiatric Clinical TrialsShitij Kapur, Marcus Munafò
Neuropharmacology|June 14, 2020
Antipsychotics Circa 2020: What are we thinking?Gary Remington, Shitij Kapur
The National Medical Journal of India|January 3, 2013
Antipsychotic therapy over half a century: a tale of discovery from chlorpromazine to aripiprazoleSridhar Natesan, Shitij Kapur
Synapse (New York, N.Y.)|July 23, 2003
Anesthetics inhibit high-affinity states of dopamine D2 and other G-linked receptorsPhilip Seeman, Shitij Kapur
Pageof 25

Showing results (1-10 of 243) with videos related to

Sort By:
Pageof 25
Schizophrenia Research|May 3, 2011
What Kraepelin might say about schizophrenia: just the factsShitij Kapur
Trends in Pharmacological Sciences|July 28, 2004
How antipsychotics become anti-"psychotic"--from dopamine to salience to psychosisShitij Kapur
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|March 8, 2011
Looking for a "biological test" to diagnose"schizophrenia": are we chasing red herrings?Shitij Kapur
The American Journal of Psychiatry|December 31, 2002
Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophreniaShitij Kapur
Schizophrenia Bulletin|July 24, 2010
Antipsychotic dosing: how much but also how often?Gary Remington, Shitij Kapur
Evidence-Based Mental Health|August 16, 2002
Review: amisulpride is effective and safe for schizophreniaGary Remington, Shitij Kapur
JAMA Psychiatry|March 28, 2019
Small Sample Sizes and a False Economy for Psychiatric Clinical TrialsShitij Kapur, Marcus Munafò
Neuropharmacology|June 14, 2020
Antipsychotics Circa 2020: What are we thinking?Gary Remington, Shitij Kapur
The National Medical Journal of India|January 3, 2013
Antipsychotic therapy over half a century: a tale of discovery from chlorpromazine to aripiprazoleSridhar Natesan, Shitij Kapur
Synapse (New York, N.Y.)|July 23, 2003
Anesthetics inhibit high-affinity states of dopamine D2 and other G-linked receptorsPhilip Seeman, Shitij Kapur
Pageof 25